Drug metabolism and liver function after methyldopa withdrawal

Area of Science:

• Pharmacology
• Geriatric Medicine
• Hepatology

Background:

• Elderly females with drug-induced orthostatic reactions and resistant hypertension often receive methyldopa.
• Methyldopa's impact on liver function and drug metabolism requires further investigation, particularly in this demographic.

Purpose of the Study:

• To investigate the effects of methyldopa withdrawal on liver function and drug metabolism.
• To assess changes in serum albumin, antipyrine metabolism, and D-glucaric acid excretion post-methyldopa withdrawal.

Main Methods:

• Observational study involving ten elderly females.
• Monitoring of liver function tests, antipyrine metabolism, and urinary D-glucaric acid excretion before and after methyldopa withdrawal.

Main Results:

• Significant increases in serum albumin levels were observed 6 months after methyldopa withdrawal.
• Antipyrine metabolism and urinary D-glucaric acid excretion also showed significant increases post-withdrawal.
• These findings suggest an improvement in drug-metabolizing capacity.

Conclusions:

• Methyldopa withdrawal can positively impact liver function and drug metabolism in elderly women.
• Patients treated with methyldopa may exhibit impaired drug-metabolizing ability, even with normal liver function tests.
• Further research is warranted to understand the long-term implications of methyldopa on drug metabolism.